What type of study is this?

This is a Systematic Review study.

Cost and clinical effectiveness of fixed-dose combination therapies in the treatment of glaucoma patients: a systematic review

View Full Paper

Ask AI

Bookmark

Authors

Systematic review shows cost-effectiveness of fixed-dose combinations in glaucoma treatment, highlighting variable regional effectiveness.

TT-FDC is more cost-effective than LT-FDC in several regions, reducing long-term costs and slowing vision loss progression.
Cost-effectiveness varies regionally; while TT-FDC excels in Europe and the Philippines, LT-FDC is preferable in China due to lower daily costs.
Both fixed-dose combinations improve adherence to treatment due to easier administration for patients.
Individual treatment selection is crucial based on local healthcare dynamics and access to medications.

Umarova et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Systematic review shows cost-effectiveness of fixed-dose combinations in glaucoma treatment, highlighting variable regional effectiveness.